Kheiron’s Breast Cancer Screening Software Receives CE Mark

Kheiron Medical Technologies has been granted the CE Mark for its deep learning-based breast cancer screening software, making it the first UK company to receive the mark for deep learning radiology software.

The CE approval means that European healthcare providers can use the software as secondary analyzers of mammographic images in breast cancer screenings.

In a clinical study, the software performed better than the average national standards for breast cancer screening. It uses artificial neural networks and high performance computing to evaluate the medical images.

The company is currently seeking FDA approval for the software.